Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TET Systems is a private biotechnology company based in Heidelberg, Germany, that manages and licenses the proprietary Tet Technology. Developed by Prof. Dr. Hermann Bujard and his team at Heidelberg University, the Tet-Off and Tet-On systems allow for the precise, reversible, and dose-dependent control of gene expression in eukaryotic cells and transgenic organisms. The company's business model focuses on providing licenses to pharmaceutical and biotechnology companies for use in drug discovery, target validation, and the development of gene and cell therapies. With hundreds of licensees worldwide, TET Systems' technology is considered a gold standard in conditional gene expression research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TET Systems Holding.